CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 719 of 859
Non-Antibody Products
Page 719 of 859
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Salazinic Acid | A depsidone lichen metabolite; active against B. cereus, B. subtilis, S. a… | 5 mg | 29885-5 | More Info |
| Salbutamol | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 10 mg | 21003-10 | More Info |
| Salbutamol | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 25 mg | 21003-25 | More Info |
| Salbutamol | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 250 mg | 21003-250 | More Info |
| Salbutamol | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 50 mg | 21003-50 | More Info |
| Salbutamol-d9 | An internal standard for the quantification of salbutamol by GC- or LC-MS | 1 mg | 25234-1 | More Info |
| Salbutamol-d9 | An internal standard for the quantification of salbutamol by GC- or LC-MS | 500 µg | 25234-500 | More Info |
| Salbutamol (hydrochloride) | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 10 mg | 23991-10 | More Info |
| Salbutamol (hydrochloride) | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 25 mg | 23991-25 | More Info |
| Salbutamol (hydrochloride) | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 5 mg | 23991-5 | More Info |
| Salbutamol (hydrochloride) | A β2-AR agonist (Kd = 759 nM in a radioligand binding assay using CHO… | 50 mg | 23991-50 | More Info |
| Salcaprozate (sodium salt) | An intestinal permeation enhancer; increases jejunal accumulation of the b… | 1 g | 36505-1 | More Info |
| Salcaprozate (sodium salt) | An intestinal permeation enhancer; increases jejunal accumulation of the b… | 250 mg | 36505-250 | More Info |
| Salcaprozate (sodium salt) | An intestinal permeation enhancer; increases jejunal accumulation of the b… | 5 g | 36505-5 | More Info |
| Salcaprozate (sodium salt) | An intestinal permeation enhancer; increases jejunal accumulation of the b… | 500 mg | 36505-500 | More Info |
| Salermide | An inhibitor of SIRT1 and SIRT2, causing tumor-specific apopoptic cell dea… | 10 mg | 13178-10 | More Info |
| Salermide | An inhibitor of SIRT1 and SIRT2, causing tumor-specific apopoptic cell dea… | 100 mg | 13178-100 | More Info |
| Salermide | An inhibitor of SIRT1 and SIRT2, causing tumor-specific apopoptic cell dea… | 5 mg | 13178-5 | More Info |
| Salermide | An inhibitor of SIRT1 and SIRT2, causing tumor-specific apopoptic cell dea… | 50 mg | 13178-50 | More Info |
| Salicin | An alcoholic β-glucoside derived from willow bark that produces anti-… | 10 g | 17357-10 | More Info |
| Salicin | An alcoholic β-glucoside derived from willow bark that produces anti-… | 100 g | 17357-100 | More Info |
| Salicin | An alcoholic β-glucoside derived from willow bark that produces anti-… | 25 g | 17357-25 | More Info |
| Salicin | An alcoholic β-glucoside derived from willow bark that produces anti-… | 50 g | 17357-50 | More Info |
| 1-Salicylate Glucuronide | A metabolite of salicylic acid and aspirin | 1 mg | 34820-1 | More Info |
| 1-Salicylate Glucuronide | A metabolite of salicylic acid and aspirin | 5 mg | 34820-5 | More Info |
| Salicylcurcumin | A synthetic curcuminoid with antioxidant and anticarcinogenic properties;… | 1 mg | 11878-1 | More Info |
| Salicylcurcumin | A synthetic curcuminoid with antioxidant and anticarcinogenic properties;… | 10 mg | 11878-10 | More Info |
| Salicylcurcumin | A synthetic curcuminoid with antioxidant and anticarcinogenic properties;… | 5 mg | 11878-5 | More Info |
| Salicylic Acid | An analytical reference standard categorized as COX inhibitor metabolite;… | 100 mg | 32991-100 | More Info |
| Salicylic Acid | An analytical reference standard categorized as COX inhibitor metabolite;… | 50 mg | 32991-50 | More Info |
| Salicylic Acid-d4 | An internal standard for the quantification of salicylic acid by GC- or LC… | 10 mg | 35418-10 | More Info |
| Salicylic Acid-d4 | An internal standard for the quantification of salicylic acid by GC- or LC… | 25 mg | 35418-25 | More Info |
| Salicylic Acid-d4 | An internal standard for the quantification of salicylic acid by GC- or LC… | 5 mg | 35418-5 | More Info |
| Salicylic Acid-d4 | An internal standard for the quantification of salicylic acid by GC- or LC… | 50 mg | 35418-50 | More Info |
| Salicyluric Acid | A major metabolite of aspirin and salicylic acid | 1 g | 34813-1 | More Info |
| Salicyluric Acid | A major metabolite of aspirin and salicylic acid | 250 mg | 34813-250 | More Info |
| Salicyluric Acid | A major metabolite of aspirin and salicylic acid | 500 mg | 34813-500 | More Info |
| Salidroside | A glycoside; scavenges DPPH and ABTS radicals (EC50s = 81.54 and 30.94 &mi… | 1 mg | 13628-1 | More Info |
| Salidroside | A glycoside; scavenges DPPH and ABTS radicals (EC50s = 81.54 and 30.94 &mi… | 10 mg | 13628-10 | More Info |
| Salidroside | A glycoside; scavenges DPPH and ABTS radicals (EC50s = 81.54 and 30.94 &mi… | 5 mg | 13628-5 | More Info |
| Salidroside | A glycoside; scavenges DPPH and ABTS radicals (EC50s = 81.54 and 30.94 &mi… | 500 µg | 13628-500 | More Info |
| Saline Sodium Citrate Stock Solution (10X, pH 7.0) | A concentrated buffer solution | 1 L | 600224-1 | More Info |
| Saline Sodium Citrate Stock Solution (10X, pH 7.0) | A concentrated buffer solution | 250 mL | 600224-250 | More Info |
| Saline Sodium Citrate Stock Solution (10X, pH 7.0) | A concentrated buffer solution | 500 mL | 600224-500 | More Info |
| Saline Sodium Phosphate EDTA Stock Solution (20X, pH 6.5) | A concentrated buffer solution | 1 L | 600225-1 | More Info |
| Saline Sodium Phosphate EDTA Stock Solution (20X, pH 6.5) | A concentrated buffer solution | 250 mL | 600225-250 | More Info |
| Saline Sodium Phosphate EDTA Stock Solution (20X, pH 6.5) | A concentrated buffer solution | 500 mL | 600225-500 | More Info |
| Salinomycin | An antibacterial and coccidiostat compound that shows selective toxicity f… | 10 mg | 13579-10 | More Info |
| Salinomycin | An antibacterial and coccidiostat compound that shows selective toxicity f… | 100 mg | 13579-100 | More Info |
| Salinomycin | An antibacterial and coccidiostat compound that shows selective toxicity f… | 5 mg | 13579-5 | More Info |
| Salinomycin | An antibacterial and coccidiostat compound that shows selective toxicity f… | 50 mg | 13579-50 | More Info |
| Salinosporamide A | An orally bioactive proteasome inhibitor; irreversibly inhibits all three… | 100 µg | 10007311-100 | More Info |
| Salmeterol-d3 | An internal standard for the quantification of salmeterol by GC- or LC-MS | 1 mg | 26449-1 | More Info |
| Salmeterol-d3 (xinafoate) | An internal standard for the quantification of salmeterol by GC- or LC-MS | 1 mg | 27191-1 | More Info |
| Salmeterol-d3 (xinafoate) | An internal standard for the quantification of salmeterol by GC- or LC-MS | 500 µg | 27191-500 | More Info |
| Salmeterol (xinafoate) | A long-acting β2-AR agonist (EC50s = 0.79, 63.1, and 9.4 nM for &beta… | 10 mg | 16009-10 | More Info |
| Salmeterol (xinafoate) | A long-acting β2-AR agonist (EC50s = 0.79, 63.1, and 9.4 nM for &beta… | 100 mg | 16009-100 | More Info |
| Salmeterol (xinafoate) | A long-acting β2-AR agonist (EC50s = 0.79, 63.1, and 9.4 nM for &beta… | 25 mg | 16009-25 | More Info |
| Salmeterol (xinafoate) | A long-acting β2-AR agonist (EC50s = 0.79, 63.1, and 9.4 nM for &beta… | 50 mg | 16009-50 | More Info |
| (S)-α-Methylbenzyl Ricinoleamide | A fatty acid amide derived from ricinoleic acid and methyl benzylamine tha… | 1 mg | 17546-1 | More Info |
| (S)-α-Methylbenzyl Ricinoleamide | A fatty acid amide derived from ricinoleic acid and methyl benzylamine tha… | 10 mg | 17546-10 | More Info |
| (S)-α-Methylbenzyl Ricinoleamide | A fatty acid amide derived from ricinoleic acid and methyl benzylamine tha… | 25 mg | 17546-25 | More Info |
| (S)-α-Methylbenzyl Ricinoleamide | A fatty acid amide derived from ricinoleic acid and methyl benzylamine tha… | 5 mg | 17546-5 | More Info |
| Salsalate | An NSAID and a prodrug form of salicylic acid; inhibits PGE2 production in… | 100 g | 11911-100 | More Info |
| Salsalate | An NSAID and a prodrug form of salicylic acid; inhibits PGE2 production in… | 25 g | 11911-25 | More Info |
| Salsalate | An NSAID and a prodrug form of salicylic acid; inhibits PGE2 production in… | 50 g | 11911-50 | More Info |
| Salubrinal | A selective phosphatase inhibitor which prevents dephosphorylation of eIF2… | 1 mg | 14735-1 | More Info |
| Salubrinal | A selective phosphatase inhibitor which prevents dephosphorylation of eIF2… | 10 mg | 14735-10 | More Info |
| Salubrinal | A selective phosphatase inhibitor which prevents dephosphorylation of eIF2… | 25 mg | 14735-25 | More Info |
| Salubrinal | A selective phosphatase inhibitor which prevents dephosphorylation of eIF2… | 5 mg | 14735-5 | More Info |
| Salvianolic Acid A | An antioxidant and free radical scavenging compound extracted from S. milt… | 1 mg | 17800-1 | More Info |
| Salvianolic Acid A | An antioxidant and free radical scavenging compound extracted from S. milt… | 10 mg | 17800-10 | More Info |
| Salvianolic Acid A | An antioxidant and free radical scavenging compound extracted from S. milt… | 25 mg | 17800-25 | More Info |
| Salvianolic Acid A | An antioxidant and free radical scavenging compound extracted from S. milt… | 5 mg | 17800-5 | More Info |
| Salvianolic Acid B | An antioxidant and free radical scavenging compound extracted from S. milt… | 1 mg | 9001577-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile